Lee KS - Search Results

1

Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases.

Sohn SK, Kim DH, Kim JG, Sung WJ, Baek JH, Lee NY, Won DI, Suh JS, Lee KS, Lee KB. Sohn SK, et al. Among authors: lee kb, lee ks, lee ny. Eur J Haematol. 2004 Jun;72(6):430-6. doi: 10.1111/j.1600-0609.2004.00249.x. Eur J Haematol. 2004. PMID: 15128422

2

Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization.

Sohn SK, Kim JG, Sung WJ, Kim DH, Suh JS, Lee KS, Lee KB. Sohn SK, et al. Among authors: lee kb, lee ks. J Clin Apher. 2003;18(4):186-9. doi: 10.1002/jca.10075. J Clin Apher. 2003. PMID: 14699595

3

Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation.

Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS, Lee KB. Kim DH, et al. Among authors: lee kb, lee ks. Br J Haematol. 2004 Apr;125(2):217-24. doi: 10.1111/j.1365-2141.2004.04891.x. Br J Haematol. 2004. PMID: 15059145 Free article.

4

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.

Kim JG, Sohn SK, Kim DH, Lee NY, Suh JS, Lee KS, Lee KB. Kim JG, et al. Among authors: lee kb, lee ks, lee ny. Eur J Haematol. 2004 Jul;73(1):56-61. doi: 10.1111/j.1600-0609.2004.00247.x. Eur J Haematol. 2004. PMID: 15182339 Clinical Trial.

5

Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation.

Kim DH, Sohn SK, Kim JG, Lee NY, Sung WJ, Baek JH, Suh JS, Lee KS, Lee KB. Kim DH, et al. Among authors: lee kb, lee ks, lee ny. Ann Hematol. 2005 Jan;84(1):25-32. doi: 10.1007/s00277-004-0942-z. Epub 2004 Sep 3. Ann Hematol. 2005. PMID: 15349754

6

Mobilization effects of G-CSF, GM-CSF, and darbepoetin-alpha for allogeneic peripheral blood stem cell transplantation.

Kim SN, Moon JH, Kim JG, Chae YS, Cho YY, Lee SJ, Kim YJ, Lee YJ, Suh JS, Lee KS, Sohn SK. Kim SN, et al. Among authors: lee sj, lee ks, lee yj. J Clin Apher. 2009;24(5):173-9. doi: 10.1002/jca.20207. J Clin Apher. 2009. PMID: 19753648 Clinical Trial.

7

Clinical significance of autoantibody expression in allogeneic stem-cell recipients.

Moon JH, Lee SJ, Kim JG, Chae YS, Kim SN, Kang BW, Suh JS, Lee KS, Sohn SK. Moon JH, et al. Among authors: lee sj, lee ks. Transplantation. 2009 Jul 27;88(2):242-50. doi: 10.1097/TP.0b013e3181ac6885. Transplantation. 2009. PMID: 19623021

8

Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.

Kim JG, Sohn SK, Kim DH, Baek JH, Lee NY, Suh JS, Chae SC, Lee KS, Lee KB. Kim JG, et al. Among authors: lee kb, lee ks, lee ny. Leuk Lymphoma. 2005 Jun;46(6):885-91. doi: 10.1080/10428190500054491. Leuk Lymphoma. 2005. PMID: 16019534

9

Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes.

Kim DH, Lee NY, Sung WJ, Baek JH, Kim JG, Sohn SK, Suh JS, Lee KS, Lee KB. Kim DH, et al. Among authors: lee kb, lee ks, lee ny. Acta Haematol. 2005;114(2):78-83. doi: 10.1159/000086579. Acta Haematol. 2005. PMID: 16103629

10

Prognostic scoring model based on multi-drug resistance status and cytogenetics in adult patients with acute myeloid leukemia.

Kim DH, Lee NY, Baek JH, Kim JG, Sohn SK, Suh JS, Lee KS, Lee KB. Kim DH, et al. Among authors: lee kb, lee ks, lee ny. Leuk Lymphoma. 2006 Mar;47(3):461-7. doi: 10.1080/10428190500331626. Leuk Lymphoma. 2006. PMID: 16396769 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,249 results

Search Page

Filters